ASG Fundamental Analysis - AURORA SPINE CORP

Fundamental Rating

Overall ASG gets a fundamental rating of 3 out of 10. We evaluated ASG against 16 industry peers in the Health Care Equipment & Supplies industry. ASG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ASG does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ASG has reported negative net income.

ASG had a positive operating cash flow in the past year.

ASG had negative earnings in each of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: ASG reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -9.77%, ASG belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.

With an excellent Return On Equity value of -28.62%, ASG belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-9.77%
ROE	-28.62%
ROIC	N/A

ROA(3y)-12.48%

ROA(5y)-12.6%

ROE(3y)-29.77%

ROE(5y)-27.75%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ASG has a Gross Margin (59.64%) which is in line with its industry peers.

ASG's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for ASG so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	59.64%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y9.72%

GM growth 5Y13.74%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ASG does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ASG has been increased compared to 1 year ago.

Compared to 5 years ago, ASG has more shares outstanding

ASG has a worse debt/assets ratio than last year.

2.2 Solvency

ASG has an Altman-Z score of 0.21. This is a bad value and indicates that ASG is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.21, ASG belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.

The Debt to FCF ratio of ASG is 18.86, which is on the high side as it means it would take ASG, 18.86 years of fcf income to pay off all of its debts.

With an excellent Debt to FCF ratio value of 18.86, ASG belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

A Debt/Equity ratio of 0.84 indicates that ASG is somewhat dependend on debt financing.

ASG has a Debt to Equity ratio of 0.84. This is comparable to the rest of the industry: ASG outperforms 56.25% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.84
Debt/FCF	18.86
Altman-Z	0.21

ROIC/WACCN/A

WACC6.9%

2.3 Liquidity

ASG has a Current Ratio of 2.03. This indicates that ASG is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 2.03, ASG belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.

ASG has a Quick Ratio of 1.13. This is a normal value and indicates that ASG is financially healthy and should not expect problems in meeting its short term obligations.

With an excellent Quick ratio value of 1.13, ASG belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.03
Quick Ratio	1.13

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ASG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.18%.

Looking at the last year, ASG shows a quite strong growth in Revenue. The Revenue has grown by 14.28% in the last year.

ASG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.51% yearly.

EPS 1Y (TTM)-13.18%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-30%

Revenue 1Y (TTM)14.28%

Revenue growth 3Y18.54%

Revenue growth 5Y9.51%

Sales Q2Q%10.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASG. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ASG is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.

100.00% of the companies in the same industry are more expensive than ASG, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	82.85
EV/EBITDA	63.03

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ASG does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AURORA SPINE CORP

TSX-V:ASG (10/20/2025, 7:00:00 PM)

0.29

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)08-20 2025-08-20

Earnings (Next)10-22 2025-10-22

Inst Owners0%

Inst Owner ChangeN/A

Ins Owners25.16%

Ins Owner ChangeN/A

Market Cap22.39M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.87
P/FCF	82.85
P/OCF	22.17
P/B	4.04
P/tB	4.98
EV/EBITDA	63.03

EPS(TTM)-0.02

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0

FCFY1.21%

OCF(TTM)0.01

OCFY4.51%

SpS0.33

BVpS0.07

TBVpS0.06

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-9.77%
ROE	-28.62%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	59.64%
FCFM	1.05%

ROA(3y)-12.48%

ROA(5y)-12.6%

ROE(3y)-29.77%

ROE(5y)-27.75%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y9.72%

GM growth 5Y13.74%

F-Score3

Asset Turnover1.59

Health

		Industry Rank	Sector Rank
Debt/Equity	0.84
Debt/FCF	18.86
Debt/EBITDA	11.04
Cap/Depr	50.45%
Cap/Sales	2.87%
Interest Coverage	N/A
Cash Conversion	238.59%
Profit Quality	N/A
Current Ratio	2.03
Quick Ratio	1.13
Altman-Z	0.21

F-Score3

WACC6.9%

ROIC/WACCN/A

Cap/Depr(3y)69.84%

Cap/Depr(5y)82.94%

Cap/Sales(3y)4.27%

Cap/Sales(5y)5.21%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-13.18%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-30%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)14.28%

Revenue growth 3Y18.54%

Revenue growth 5Y9.51%

Sales Q2Q%10.24%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y3.69%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y124.42%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y355.27%

OCF growth 3YN/A

OCF growth 5Y319.03%

AURORA SPINE CORP (ASG.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens